MedPageToday -- The generally favorable prognosis for small breast tumors might improve even more with adjuvant trastuzumab (Herceptin) for small HER2-positive tumors, British oncologists argue in a review of the issue.
MedPageToday -- The generally favorable prognosis for small breast tumors might improve even more with adjuvant trastuzumab (Herceptin) for small HER2-positive tumors, British oncologists argue in a review of the issue.
